Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide and Postprandial Endothelial Dysfunction
NCT01181986Phase 4Completed
- Sponsor
- Carl T. Hayden VA Medical Center
- Start
- Aug 2010
- Primary completion
- Dec 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Carl T. Hayden VA Medical Center. Started Aug 2010; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01181986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181986.